University Hospital Regensburg, Regensburg, Germany.
Arthritis Rheumatol. 2014 Oct;66(10):2685-93. doi: 10.1002/art.38746.
Observations in both animal models of arthritis and patients with rheumatoid arthritis (RA) suggest a role for dopamine and its receptors in RA. Because synovial fibroblasts (SFs) contribute to inflammation and joint destruction in RA, the aim of this study was to investigate dopaminergic pathways in SFs obtained from patients with RA and, for comparison, in SFs from patients with osteoarthritis (OA) undergoing knee joint replacement surgery.
The expression of all dopamine receptors (D1 -D5 ) and dopamine transporter was assessed by immunofluorescence and immunohistochemical staining. The levels of dopamine receptor and tyrosine hydroxylase messenger RNA were measured by real-time polymerase chain reaction. The intracellular content of dopamine, its precursor, and its main metabolites was assayed by high-performance liquid chromatography. The influence of dopamine on proinflammatory interleukin-6 (IL-6) and IL-8, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 (TIMP-1) and TIMP-2 was studied in SFs.
SFs possess an intrinsic dopaminergic system, including dopamine receptors, dopamine transporter, and tyrosine hydroxylase, and contain dopamine, its precursor, and its main metabolites. SFs from patients with RA, in comparison with those from patients with OA, showed increased expression of dopamine receptors D1 and D5 , and exogenous dopamine strongly inhibited the production of IL-8 in patients with RA.
SFs from patients with RA and patients with OA show a dopaminergic phenotype. The expression of D1-like dopamine receptors was higher in RASFs, and this increased expression may lead to antiinflammatory effects, as demonstrated by the expression of IL-8. Studies in animal models and patients with RA are needed to assess the therapeutic potential of endogenous, local production of dopamine in synoviocytes.
关节炎动物模型和类风湿关节炎(RA)患者的观察结果表明,多巴胺及其受体在 RA 中起作用。由于滑膜成纤维细胞(SFs)有助于 RA 中的炎症和关节破坏,因此本研究旨在研究从 RA 患者中获得的 SFs 中的多巴胺能途径,并与接受膝关节置换手术的骨关节炎(OA)患者的 SFs 进行比较。
通过免疫荧光和免疫组织化学染色评估所有多巴胺受体(D1-D5)和多巴胺转运体的表达。通过实时聚合酶链反应测量多巴胺受体和酪氨酸羟化酶信使 RNA 的水平。通过高效液相色谱法测定多巴胺、其前体及其主要代谢物的细胞内含量。研究多巴胺对促炎性白细胞介素-6(IL-6)和 IL-8、基质金属蛋白酶 3 以及金属蛋白酶 1(TIMP-1)和 TIMP-2 的影响在 SFs 中。
SFs 具有内在的多巴胺能系统,包括多巴胺受体、多巴胺转运体和酪氨酸羟化酶,并包含多巴胺、其前体及其主要代谢物。与 OA 患者相比,RA 患者的 SFs 显示多巴胺受体 D1 和 D5 的表达增加,外源性多巴胺强烈抑制 RA 患者 IL-8 的产生。
RA 和 OA 患者的 SFs 表现出多巴胺能表型。RA 患者的 D1 样多巴胺受体表达更高,这种表达增加可能导致抗炎作用,如 IL-8 的表达所示。需要在动物模型和 RA 患者中进行研究,以评估内源性、局部产生的多巴胺在滑膜细胞中的治疗潜力。